Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus
- PMID: 33341198
- DOI: 10.1016/j.clindermatol.2020.06.013
Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus
Abstract
Cutaneous manifestations of drug reactions are common yet vary widely in their appearance and degree of internal organ involvement. Serum sickness--like reactions, symmetrical drug-related intertriginous and flexural exanthem, granulomatous drug eruption, pseudolymphoma, and drug-induced lupus are medication-induced conditions with dermatologic presentations. Many of the conditions discussed are relatively rare but nonetheless demand our attention and understanding. Some of the conditions presented may be more likely encountered in the hospital setting, as is the case with serum sickness-like reactions and drug-induced lupus, whereas others may present to outpatient clinic for diagnosis. Given the similarities in clinical history of patients presenting with these conditions, an understanding of the clinical presentation, pathophysiology, culprit medications, histologic appearance, and serologic characteristics is warranted to correctly diagnose and manage these uncommon adverse reactions. We also discuss how to differentiate some of these conditions from more serious mimickers, as in the case of pseudolymphoma drug reaction mimicking a true lymphoma and drug-induced lupus mimicking acute systemic lupus erythematosus.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.Dermatol Online J. 2023 Aug 15;29(4). doi: 10.5070/D329461905. Dermatol Online J. 2023. PMID: 37921816
-
Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.Arch Dermatol Res. 2024 May 25;316(6):279. doi: 10.1007/s00403-024-03083-0. Arch Dermatol Res. 2024. PMID: 38796524
-
Pediatric drug eruptions.Clin Dermatol. 2020 Nov-Dec;38(6):629-640. doi: 10.1016/j.clindermatol.2020.06.014. Epub 2020 Jun 29. Clin Dermatol. 2020. PMID: 33341197 Review.
-
Symmetrical drug-related intertriginous and flexural exanthema due to clindamycin.BMJ Case Rep. 2019 Aug 2;12(8):e230077. doi: 10.1136/bcr-2019-230077. BMJ Case Rep. 2019. PMID: 31377719 Free PMC article.
-
A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.Am J Clin Dermatol. 2011 Jun 1;12(3):171-80. doi: 10.2165/11539080-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21469762 Review.
Cited by
-
Non-IgE-mediated drug-induced hypersensitivity reactions in pediatrics.Curr Opin Pediatr. 2024 Dec 1;36(6):674-683. doi: 10.1097/MOP.0000000000001395. Epub 2024 Aug 19. Curr Opin Pediatr. 2024. PMID: 39254665 Review.
-
Case Report of Serum Sickness-like Reaction following the First Dose of the Chimpanzee Adenovirus-Vectored AstraZeneca COVID-19 Vaccine, ChAdOx1.Vaccines (Basel). 2023 Feb 17;11(2):467. doi: 10.3390/vaccines11020467. Vaccines (Basel). 2023. PMID: 36851343 Free PMC article.
-
Zoledronic acid-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).BMJ Case Rep. 2021 Sep 13;14(9):e245326. doi: 10.1136/bcr-2021-245326. BMJ Case Rep. 2021. PMID: 34518192 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
